Comparison Of Femoral Block And Middle Adductor Canal Block In Patients With Knee Arthroplasty
1 other identifier
interventional
52
1 country
1
Brief Summary
Femoral and adductor nerve blocks with ultrasonography(USG) guidance are used effectively and efficiently in post-operative pain management in lower extremity surgical procedures. However, the superiority of these two blocks to each other is still controversial. In this prospective, randomized, double-blind study, patients who underwent elective unilateral knee arthroplasty under spinal anesthesia, will be performed postoperative femoral block or middle adductor canal block with the guidance of USG.Patients who underwent spinal anesthesia and needed sedoanalgesia and who had to switch to general anesthesia will be excluded from the study. The patients will be divided into two groups by simple randomization. Since a total of 52 patients should be included in the study as a result of the power analysis (G-power 3.1); It is planned to take approximately 26 patients for each group.The anesthesiologist, who follows the pain control and mobilization after the block, will not know which study group the patient is in. The blocks will be performed behind the cover while the patient is under spinal anesthesia (Thus, the point of application of the block will not be noticed). In this way, the patient and the anesthesiologist who follows the parameters after the block will be blind to patient's arm. In the first group, 0.25% 20 ml of local anesthetic and middle adductor canal block, in the second group 0.25% 20 ml of local anesthetic and femoral nerve block will be applied We will compare these two blocks in terms of early mobilization, postoperative pain control, motor, and sensory block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2021
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedStudy Start
First participant enrolled
April 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2022
CompletedFebruary 24, 2021
February 1, 2021
6 months
February 22, 2021
February 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 0th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 0th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 2nd hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 2nd hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 4th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 4th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 6th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 6th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 8th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 8th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 12th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 12th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 24th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 24th hour postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient according to NRS
At 6 months postoperatively
Post-operative pain assessed by Numeric Rating Scale(NRS)
Pain scores will be recorded as reported by the patient while knee flexion according to NRS
At 6 months postoperatively
Ambulation time
First time a patients can walk around independently
48 hours postoperatively
NRS at Ambulation
NRS when first time a patients can walk around independently
48 hours postoperatively
Secondary Outcomes (3)
Time of First Rescue Opioid
48 hours postoperatively
Time of Return of Sensory Block
24 hours postoperatively
Time of Return of Motor Block
24 hours postoperatively
Study Arms (2)
Group 1 Middle Adductor Canal Block
ACTIVE COMPARATORUltrasound Guided Middle Adductor Canal Block: 20 ml Bupivacaine 0.25% Injectable Solution will be administered for middle adductor canal block. 10 ml %0,5 Bupivacaine will be diluted with 10 ml saline solution.
Group 2 Femoral Nerve Block.
ACTIVE COMPARATORUltrasound Guided Femoral Nerve Block: 20 ml Bupivacaine 0.25% Injectable Solution will be administered for femoral nerve block. 10 ml %0,5 Bupivacaine will be diluted with 10 ml saline solution.
Interventions
Middle adductor canal block will be applied post-operatively with guidance of USG. Drug:Bupivacaine 0.25% Injectable Solution
Femoral nerve block will be applied post-operatively with guidance of USG. Drug:Bupivacaine 0.25% Injectable Solution
10 ml %0,5 Bupivacaine will be diluted with 10 ml saline solution. Bupivacaine 0.25% Injectable Solution
Patients will be placed in the lateral decubitus position.Subarachnoid space will be entered through the most suitable intervertebral space.Bupivacaine 0.5% Heavy will be given in the appropriate dose.
Eligibility Criteria
You may qualify if:
- ASA1-2-3 patients who will undergo unilateral elective primary total knee prosthesis surgery with consent for the study
- Patients whose operation has been successfully completed with spinal anesthesia
You may not qualify if:
- Refusal of the patient to work
- Patients under 18 years of age
- Patients who have undergone an anesthesia technique other than spinal anesthesia for any reason (general anesthesia, sedoanelgesia, laryngeal mask application, etc.)
- Those with known local anesthetic allergies
- Body mass index\> 35 patient groups
- Skin infection at the injection site
- Coagulopathy and use of anticoagulant therapy
- Uncontrolled diabetic patients
- Uncooperative patient
- Physiological and emotional lability
- Prolonged surgical intervention
- Patient with limitation of mobilization and movement before the operation, other than the operation reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İzmir Bozyaka Training and Research Hospital
Izmir, 35170, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zeki Tuncel Tekgül
İzmir Bozyaka Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology Resident
Study Record Dates
First Submitted
February 22, 2021
First Posted
February 24, 2021
Study Start
April 16, 2021
Primary Completion
October 16, 2021
Study Completion
April 16, 2022
Last Updated
February 24, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share